首页> 外文期刊>BMC Health Services Research >Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study
【24h】

Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study

机译:根据南非的常规实验室数据估算艾滋病毒的治疗开始日期:一项验证研究

获取原文
           

摘要

Background Poor clinical record keeping hinders health systems monitoring and patient care in many low resource settings. We develop and validate a novel method to impute dates of antiretroviral treatment (ART) initiation from routine laboratory data in South Africa’s public sector HIV program. This method will enable monitoring of the national ART program using real-time laboratory data, avoiding the error potential of chart review. Methods We developed an algorithm to impute ART start dates based on the date of a patient’s “ART workup”, i.e. the laboratory tests used to determine treatment readiness in national guidelines, and the time from ART workup to initiation based on clinical protocols (21?days). To validate the algorithm, we analyzed data from two large clinical HIV cohorts: Hlabisa HIV Treatment and Care Programme in rural KwaZulu-Natal; and Right to Care Cohort in urban Gauteng. Both cohorts contain known ART initiation dates and laboratory results imported directly from the National Health Laboratory Service. We assessed median time from ART workup to ART initiation and calculated sensitivity (SE), specificity (SP), positive predictive value (PPV), and negative predictive value (NPV) of our imputed start date vs. the true start date within a 6?month window. Heterogeneity was assessed across individual clinics and over time. Results We analyzed data from over 80,000 HIV-positive adults. Among patients who had a workup and initiated ART, median time to initiation was 16?days (IQR 7,31) in Hlabisa and 21 (IQR 8,43) in RTC cohort. Among patients with known ART start dates, SE of the imputed start date was 83% in Hlabisa and 88% in RTC, indicating this method accurately predicts ART start dates for about 85% of all ART initiators. In Hlabisa, PPV was 95%, indicating that for patients with a lab workup, true start dates were predicted with high accuracy. SP (100%) and NPV (92%) were also very high. Conclusions Routine laboratory data can be used to infer ART initiation dates in South Africa’s public sector. Where care is provided based on protocols, laboratory data can be used to monitor health systems performance and improve accuracy and completeness of clinical records.
机译:背景技术不良的临床记录保存在许多资源匮乏的环境中阻碍了卫生系统的监视和患者护理。我们开发并验证了一种新方法,可以根据南非公共部门HIV计划中的常规实验室数据来估算抗逆转录病毒治疗(ART)的起始日期。这种方法将允许使用实时实验室数据监视国家ART计划,从而避免了图表审查的潜在错误。方法我们开发了一种算法,可根据患者的“ ART检查”日期(即国家标准中用于确定治疗准备情况的实验室测试,以及根据临床方案从ART检查开始到开始的时间)来估算ART的开始日期(21?天)。为了验证该算法,我们分析了来自两个大型临床HIV队列的数据:KwaZulu-Natal农村的Hlabisa HIV治疗和护理计划;以及豪登省城市护理权队列。这两个队列均包含已知的抗病毒治疗起始日期和直接从国家卫生实验室服务局导入的实验室结果。我们评估了从ART检查到开始ART的中位时间,并计算了6个月内推算开始日期与真实开始日期之间的敏感性(SE),特异性(SP),阳性预测值(PPV)和阴性预测值(NPV)月窗。跨诊所对异质性进行了评估。结果我们分析了来自80,000多名HIV阳性成年人的数据。在接受了检查和启动抗逆转录病毒治疗的患者中,Hlabisa的中位起始时间为16天(IQR 7,31),RTC队列中位起始时间为21天(IQR 8,43)。在具有已知ART起始日期的患者中,Hlabisa中估算的起始日期的SE为83%,RTC中为88%,这表明该方法可以准确预测所有ART引发剂中约85%的ART起始日期。在Hlabisa中,PPV为95%,这表明对于进行实验室检查的患者,可以准确预测真正的开始日期。 SP(100%)和NPV(92%)也很高。结论常规实验室数据可用于推断南非公共部门抗病毒治疗的起始日期。根据协议提供护理的地方,实验室数据可用于监视卫生系统的性能并提高临床记录的准确性和完整性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号